Search Results - "Granzow, Michaela"
-
1
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Published in Journal of hepatology (01-10-2010)“…Background & Aims Activation of hepatic stellate cells (HSC) and transdifferentiation to myofibroblasts following liver injury is the main culprit for hepatic…”
Get full text
Journal Article -
2
Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
Published in Gastroenterology (New York, N.Y. 1943) (01-10-2013)“…Background & Aims Splanchnic vascular hypocontractility with subsequent increased portal venous inflow leads to portal hypertension. Although the…”
Get full text
Journal Article -
3
Angiotensin‐II type 1 receptor‐mediated Janus kinase 2 activation induces liver fibrosis
Published in Hepatology (Baltimore, Md.) (01-07-2014)“…Activation of the renin angiotensin system resulting in stimulation of angiotensin‐II (AngII) type I receptor (AT1R) is an important factor in the development…”
Get full text
Journal Article -
4
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Published in Journal of hepatology (01-12-2012)“…Background & Aims Rho-kinase activation mediates cell contraction and increases intrahepatic resistance and consequently portal pressure in liver cirrhosis…”
Get full text
Journal Article -
5
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
Published in Laboratory investigation (01-10-2012)“…Hepatic myofibroblasts (MFB) show increased proliferation, migration and collagen production, which are crucial for hepatic fibrogenesis. Atorvastatin…”
Get full text
Journal Article -
6
Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
Published in Liver international (01-07-2011)“…Background: Alcohol is a common cause of hepatic liver injury with steatosis and fibrosis. Cannabinoid receptors (CB) modulate steatosis, inflammation and…”
Get full text
Journal Article -
7
Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
Published in Frontiers in physiology (01-01-2013)“…Progression of liver fibrosis is characterized by synthesis and degradation of extracellular matrix (ECM). Matrix-metalloproteinases (MMP) cleave collagen…”
Get full text
Journal Article -
8
Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
Published in Scientific reports (28-09-2015)“…Liver cirrhosis but also portal vein obstruction cause portal hypertension (PHT) and angiogenesis. This study investigated the differences of angiogenesis in…”
Get full text
Journal Article -
9
TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor
Published in Scientific reports (12-08-2019)“…Prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing. Resulting fibrosis and portal hypertension, as a possible secondary event, may…”
Get full text
Journal Article -
10
Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis
Published in Hepatology (Baltimore, Md.) (01-12-2009)“…Increased intrahepatic resistance and splanchnic blood flow cause portal hypertension in liver cirrhosis. Nonselective β‐adrenoceptor (β‐AR) antagonists have…”
Get full text
Journal Article -
11
The Archaeal Lsm Protein Binds to Small RNAs
Published in The Journal of biological chemistry (05-11-2010)“…Proteins of the Lsm family, including eukaryotic Sm proteins and bacterial Hfq, are key players in RNA metabolism. Little is known about the archaeal…”
Get full text
Journal Article -
12
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis
Published in Laboratory investigation (01-02-2011)“…Portal hypertension in cirrhosis depends on increased intrahepatic vascular resistance, which is explained by fibrosis and intrahepatic hyperresponsiveness to…”
Get full text
Journal Article -
13
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
Published in American journal of physiology: Gastrointestinal and liver physiology (15-04-2012)“…The endocannabinoid system is a crucial regulator of hepatic fibrogenesis. We have previously shown that the endocannabinoid anandamide (AEA) is a lipid…”
Get more information
Journal Article -
14
Small RNAs of the halophilic archaeon Haloferax volcanii
Published in Biochemical Society transactions (01-02-2009)“…In recent years, sRNAs (small non-coding RNAs) have been found to be abundant in eukaryotes and bacteria and have been recognized as a novel class of gene…”
Get more information
Journal Article -
15
-
16
Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis
Published in Hepatology (Baltimore, Md.) (01-12-2009)“…Increased intrahepatic resistance and splanchnic blood flow cause portal hypertension in liver cirrhosis. Nonselective beta-adrenoceptor (beta-AR) antagonists…”
Get full text
Journal Article